Evidence map›Paper›PMID 37049953›Full record

ReviewMolecules (Basel, Switzerland)2023

The Synthesis and Biological Applications of the 1,2,3-Dithiazole Scaffold.

Andreas S Kalogirou, Hans J Oh, Christopher R M Asquith

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Synthesis of Heteroaromatic Compounds.Molecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andreas S KalogirouDepartment of Life Sciences, School of Sciences, European University Cyprus, 6 Diogenis Str., Engomi, P.O. Box 22006, Nicosia 1516, Cyprus.ORCID 0000-0002-5476-5805
Hans J OhDepartment of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0009-0007-2354-080X
Christopher R M AsquithDepartment of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0001-5871-3458

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 1,2,3-dithiazole is an underappreciated scaffold in medicinal chemistry despite possessing a wide variety of nascent pharmacological activities. The scaffold has a potential wealth of opportunities within these activities and further afield. The 1,2,3-dithiazole scaffold has already been reported as an antifungal, herbicide, antibacterial, anticancer agent, antiviral, antifibrotic, and is a melanin and Arabidopsis gibberellin 2-oxidase inhibitor. These structure activity relationships are discussed in detail, along with insights and future directions. The review also highlights selected synthetic strategies developed towards the 1,2,3-dithiazole scaffold, how these are integrated to accessibility of chemical space, and to the prism of current and future biological activities.

Indexed as

Anti-Bacterial AgentsAntiviral AgentsAntifungal AgentsMelaninsStructure-Activity RelationshipAnti-Bacterial AgentsAntifungal AgentsAntiviral AgentsMelanins1,2,3-dithiazoleantibacterialanticancerantifibroticantifungalantimicrobialantiviralappel saltdisulfide bridgeherbicidal

Identifiers

PMID37049953
PMCPMC10096614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.